Clinical Trials Browser

Phase 2 × Gliosarcoma × Gefitinib × Clear all

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT01310855 2017-05-31

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Terminated

38 enrolled 8 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00016991 2013-06-20

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Phase 2 Completed

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Clinical Trials

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse